Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Toshie Mashiba"'
Autor:
Atsuhiro Morita, Nobuharu Tamaki, Haruhiko Kobashi, Nami Mori, Keiji Tsuji, Shintaro Takaki, Chitomi Hasebe, Takehiro Akahane, Hironori Ochi, Toshie Mashiba, Naohito Urawa, Hideki Fujii, Akeri Mitsuda, Masahiko Kondo, Chikara Ogawa, Yasushi Uchida, Ryoichi Narita, Hiroyuki Marusawa, Yoshihito Kubotsu, Tomomichi Matsushita, Masaya Shigeno, Hideo Yoshida, Katsuaki Tanaka, Eisuke Okamoto, Toyotaka Kasai, Toru Ishii, Kazuhiko Okada, Masayuki Kurosaki, Namiki Izumi
Publikováno v:
JGH Open, Vol 8, Iss 4, Pp n/a-n/a (2024)
Abstract Background and aim In patients with chronic hepatitis C, 8 weeks of glecaprevir and pibrentasvir (GLE/PIB) treatment for chronic hepatitis (non‐cirrhosis) and 12 weeks for cirrhosis have been approved in Japan. However, whether 8 weeks of
Externí odkaz:
https://doaj.org/article/0d9873a1fd55472ea90b8aee2ad5fcad
Autor:
Shun Ishido, Nobuharu Tamaki, Masayuki Kurosaki, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Toshie Mashiba, Hironori Ochi, Yutaka Yasui, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hideki Fujii, Toru Ishii, Hiroyuki Marusawa, Masahiko Kondo, Atsunori Kusakabe, Hideo Yoshida, Yasushi Uchida, Toshifumi Tada, Shinichiro Nakamura, Akari Mitsuda, Chikara Ogawa, Hirotaka Arai, Toshimitsu Murohisa, Minoru Uebayashi, Namiki Izumi
Publikováno v:
JGH Open, Vol 7, Iss 6, Pp 424-430 (2023)
Abstract Background and Aim Hepatocellular carcinoma (HCC) surveillance in low‐risk patients (annual incidence
Externí odkaz:
https://doaj.org/article/b64a2bedcc15417daad694e97d928a4c
Autor:
Makoto Morita, Tomoyuki Yokota, Ryo Yano, Michiko Amano, Hironori Ochi, Nobuaki Azemoto, Toshie Mashiba, Kouji Joko
Publikováno v:
DEN Open, Vol 2, Iss 1, Pp n/a-n/a (2022)
Abstract A 31‐year‐old man developed massive walled‐off necrosis extending into the pelvic cavity following severe acute alcoholic pancreatitis. Endoscopic ultrasound‐guided fistula drainage was performed using a lumen‐apposing metal stent,
Externí odkaz:
https://doaj.org/article/b6588c2a3030464db79a93930dd046b7
Autor:
Toshie Mashiba, Kouji Joko, Masayuki Kurosaki, Hironori Ochi, Yukio Osaki, Yuji Kojima, Ryo Nakata, Tohru Goto, Akahane Takehiro, Hiroyuki Kimura, Akeri Mitsuda, Chiharu Kawanami, Yasushi Uchida, Chikara Ogawa, Atsunori Kusakabe, Ryuichi Narita, Yasushi Ide, Takehiko Abe, Keiji Tsuji, Tadashi Kitamura, Kazuhiko Okada, Tetsuro Sohda, Masaya Shigeno, Takashi Satou, Namiki Izumi
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0194704 (2018)
This study aimed to elucidate whether interferon (IFN)-free direct-acting antiviral (DAA) therapy for hepatitis C after curative treatment of hepatocellular carcinoma (HCC) promotes HCC recurrence in a real-world large-scale cohort.This multicenter s
Externí odkaz:
https://doaj.org/article/fa8946d099b443f1b37b8da73dbc579e
Autor:
Ryo Yano, Tomoyuki Yokota, Makoto Morita, Michiko Amano, Hironori Ochi, Nobuaki Azemoto, Toshie Mashiba, Koji Joko
Publikováno v:
Internal Medicine. 62:1011-1015
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e40fe45fcfcdb5a97f2bc9c14fdaf0c2
https://doi.org/10.2169/internalmedicine.9731-22
https://doi.org/10.2169/internalmedicine.9731-22
Autor:
Daniel Q. Huang, Nobuharu Tamaki, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Hye Won Lee, Seng Gee Lim, Tae Seop Lim, Masayuki Kurosaki, Hiroyuki Marusawa, Toshie Mashiba, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Namiki Izumi, Beom Kyung Kim, Dong Hyun Sinn
Publikováno v:
Hepatology. 77:1746-1756
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef18daf340961f6246349970a165f451
https://doi.org/10.1097/hep.0000000000000037
https://doi.org/10.1097/hep.0000000000000037
Autor:
Hironori Ochi, Masayuki Kurosaki, Kouji Joko, Toshie Mashiba, Nobuharu Tamaki, Kaoru Tsuchiya, Hiroyuki Marusawa, Toshifumi Tada, Shinichiro Nakamura, Ryoichi Narita, Yasushi Uchida, Takehiro Akahane, Masahiko Kondo, Nami Mori, Shintaro Takaki, Keiji Tsuji, Atsunori Kusakabe, Koichiro Furuta, Haruhiko Kobashi, Hirotaka Arai, Michiko Nonogi, Takashi Tamada, Chitomi Hasebe, Namiki Izumi
Publikováno v:
Hepatology Research. 53:61-71
We investigated pretreatment neutrophil-to-lymphocyte ratio (NLR) for predicting survival outcomes of atezolizumab plus bevacizumab therapy for hepatocellular carcinoma (HCC) and determined the predictive ability of combined liver reserve-NLR.This re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2308b3cfd8e6e2d594e8792693a11d52
https://doi.org/10.1111/hepr.13836
https://doi.org/10.1111/hepr.13836
Autor:
Makoto Morita, Hironori Ochi, Ryo Yano, Michiko Amano, Nobuaki Azemoto, Toshie Mashiba, Tomoyuki Yokota, Kouji Joko
Publikováno v:
Kanzo. 63:417-423
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78fbb41a2f8d67643985484f18b9450b
https://doi.org/10.2957/kanzo.63.417
https://doi.org/10.2957/kanzo.63.417
Autor:
Hironori Ochi, Atsushi Hiraoka, Takaaki Tanaka, Toshie Mashiba, Hideko Ohama, Fujimasa Tada, Cao Fang, Toyoki Shimamoto, Michiko Amano, Nobuaki Azemoto, Masashi Hirooka, Tomoyuki Yokota, Yoichi Hiasa
Publikováno v:
Hepatology Research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a26975115c86151a7fc7f18bf92d5eb
https://doi.org/10.1111/hepr.13896
https://doi.org/10.1111/hepr.13896
Autor:
Ryo, Yano, Tomoyuki, Yokota, Makoto, Morita, Michiko, Amano, Hironori, Ochi, Nobuaki, Azemoto, Toshie, Mashiba, Koji, Joko
Publikováno v:
Internal medicine (Tokyo, Japan).
We herein report a 68-year-old man who underwent nephrectomy for right renal cell carcinoma 10 years prior. He remained under regular medical observation, and abdominal computed tomography showed tumors in the head and tail of the pancreas. He was di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::545f1b261916a1ee8be9108b4b2dd38b
https://pubmed.ncbi.nlm.nih.gov/36047115
https://pubmed.ncbi.nlm.nih.gov/36047115